Study on the Effectiveness and Safety of Nizubaglustat in Patients with Niemann-Pick Type C, GM1, or GM2 Gangliosidosis
- Substances:Nizubaglustat
Portugal- Participants:0–17 years · 18–64 years
- Substances:Nizubaglustat
Rare diseases
Investigational molecules
Locations
PortugalStudy on Acoramidis for Preventing Transthyretin Amyloidosis in Young People with a Genetic Risk
PortugalStudy on the Safety and Effectiveness of Inclisiran for Children Aged 6 to Under 12 with Familial Hypercholesterolemia
PortugalStudy on Abatacept for Predicting Treatment Response in Patients with Early Rheumatoid Arthritis
PortugalStudy on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis
PortugalStudy on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease
PortugalStudy on the Effectiveness of Gilteritinib and Drug Combination for Patients with Relapsed or Refractory Acute Myeloid Leukemia
PortugalStudy on Frexalimab, SAR442970, and Rilzabrutinib for Patients Aged 16-75 with Focal Segmental Glomerulosclerosis or Minimal Change Disease
PortugalStudy on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors
PortugalStudy of Durvalumab for Patients with Early Stage or Locally Advanced Non-Small Cell Lung Cancer Not Suitable for Surgery
PortugalStudy of Sarilumab for Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA)
PortugalStudy on the Effectiveness of EHSG-KF Skin Graft for Patients with Deep Partial and Full-Thickness Burns
PortugalTell us about your condition – we search every trial in Europe and connect you with the right site.